News

When Associate Professor of Otolaryngology Matthew Spitzer, PhD, was in fifth grade, his mom was diagnosed with breast cancer. She passed away while he was in college. “That was a strong motivating force for me to get involved in cancer research,” Dr. Spitzer said. Shortly thereafter, Dr. Spitzer

Cancer immunotherapy drugs have demonstrated limited effectiveness in treating prostate cancer. By contrast, radioligand therapy – a type of precision radiation treatment that uses a targeting compound to damage or destroy prostate cancer cells – has shown improved survival rates in metastatic

With a renewed Specialized Program of Research Excellence (SPORE) grant, the UC San Francisco Brain Tumor Center is receiving $12 million dollars over five years to translate scientific findings into improved care for people with brain tumors. The award marks the fifth cycle of continuous support

Despite decades of scientific progress, breast cancer remains the most common cancer among women in the United States. Experts are divided on many aspects, such as when and how often to do mammograms, how to rethink interventions for precancer lesions, and how to pinpoint risk and reduce the

It took three years and thousands of dollars in fundraising, but the legacy of a celebrated UCSF professor and researcher has now been cemented in a lecture hall for generations of learners to come. The inaugural Zena Werb Memorial Lecture in Cancer Biology took place at UCSF Parnassus Heights

A recent article in the Journal of Nuclear Medicine reports findings of a multi-center retrospective study that compares bone scan with PSMA PET for initial staging of prostate cancer. Authors include UCSF Radiology and Biomedical Imaging faculty members Thomas Hope, MD, Roxanna Juarez, MD, Miguel